Disease Activity Assessment in IBD: Clinical Indices and Biomarkers Fail to Predict Endoscopic Remission

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MIB.0000000000000341PMID 25738372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treat to target: a proposed new paradigm for the management of Crohn's disease.

  2015cited by this paper
• Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.

  2014cited by this paper
• Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.

  2014cited by this paper
• Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

  2013cited by this paper
• Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

  2013cited by this paper
• Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

  2013cited by this paper
• Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

  2012cited by this paper
• Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970–2004)

  2012cited by this paper
• C‐reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post‐hoc analysis from ACCENT I

  2012cited by this paper
• Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.

  2012cited by this paper
• Tu1303 Risk of Surgery Following Diagnosis in Adult and Pediatric Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

  2012influential reference
• Ehealth: Impact of Web-Based Treatment Optimization Solution (Traffic Light) on the Quality of Life in Crohn's Disease Patients Treated With Infliximab

  2011cited by this paper
• Dosage adjustment during long‐term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics

  2011cited by this paper
• Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI

  2010influential reference
• Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

  2010cited by this paper
• Development of the Crohn's disease digestive damage score, the Lémann score

  2010cited by this paper
• Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.

  2010cited by this paper
• Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity.

  2010cited by this paper
• E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach

  2010cited by this paper
• Endoscopic evaluation of Crohn's disease activity: Comparison of the CDEIS and the SES‐CD†

  2010cited by this paper
• Factors predicting the outcome of disease activity assessment in Crohn's disease

  2009cited by this paper
• Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C‐reactive protein, and blood leukocytes

  2009influential reference
• W1165 Clinical Assessment of Ulcerative Colitis Activity Correlates Poorly with Endoscopic Disease Activity.

  2009cited by this paper
• Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

  2008cited by this paper
• Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

  2008cited by this paper
• Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

  2008influential reference
• Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C‐reactive protein serum level

  2007cited by this paper
• Fecal Calprotectin: A Quantitative Marker of Colonic Inflammation in Children With Inflammatory Bowel Disease

  2007cited by this paper
• Predicting the Crohn's disease activity index from the harvey‐bradshaw index

  2006cited by this paper
• Correlation of C‐Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel Disease

  2005cited by this paper
• Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease

  2005cited by this paper
• Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.

  2004cited by this paper
• Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions

  1998cited by this paper
• A simple clinical colitis activity index

  1998cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper
• Simple index of Crohn's disease activity.

  1980cited by this paper

• Psychological distress predicts disease activity in inflammatory bowel disease: Results from the mind-body IBD longitudinal study

  2025cites this paper
• The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage

  2025cites this paper
• Plasma Concentration of Calprotectin, but Not Serum Concentration, Is a Predictive Biomarker for Clinical Remission in Ulcerative Colitis

  2025cites this paper
• Explainable artificial intelligence for prediction of refractory ulcerative colitis: analysis of a Japanese Nationwide Registry

  2025cites this paper
• Involvement and Role of Macrophage Polarization in Ulcerative Colitis

  2025cites this paper
• What Is Moderate to Severe Inflammatory Bowel Disease?

  2025cites this paper
• Efficacy of a Low-FODMAP Diet on the Severity of Gastrointestinal Symptoms and Quality of Life in the Treatment of Gastrointestinal Disorders—A Systematic Review of Randomized Controlled Trials

  2025cites this paper
• Effectiveness and safety of non-pharmacological therapies for the treatment of inflammatory bowel disease: a network meta-analysis

  2025cites this paper
• A radically simple, ingestible colorimetric biosensor pill for cost-effective, non-invasive monitoring of intestinal inflammation

  2025cites this paper
• Inflammatory bowel diseases (IBDs): a cross-sectional analysis of the psychological and biological mechanisms underlying intestinal and extra-intestinal symptoms—GastroPsy study protocol

  2025cites this paper
• Body mass index does not influence loss of response to tumor necrosis factor inhibitors in Crohn's disease.

  2025cites this paper
• Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores

  2025cites this paper
• The Intestinal Mucin Isoform Landscape Reveals Region-Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification

  2024cites this paper
• Peak enhancement in contrast-enhanced ultrasound for assessing endoscopic disease activity in patients with Crohn’s disease: a meta-analysis

  2024cites this paper
• Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?

  2024cites this paper
• Self-reported food intolerance, dietary supplement use and malnutrition in chronic inflammatory bowel diseases: Findings from a cross-sectional study in Lebanon

  2024cites this paper
• Predicting mucosal inflammation in IBD patients using patient-reported symptom scores and a faecal calprotectin home test: protocol for a multicentre prospective validation study

  2024cites this paper
• Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target

  2024cites this paper
• Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices.

  2024cites this paper
• Surgically-Relevant Quality of Life Thresholds for the Short Inflammatory Bowel Disease Questionnaire in Crohn's disease.

  2024cites this paper
• Deficits in geriatric assessment are important in relation to fatigue in older patients with Inflammatory Bowel Disease.

  2024cites this paper
• Assessing acute colitis induced by dextran sulfate sodium in rats and its impact on gastrointestinal fluids

  2023cites this paper
• To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease

  2023cites this paper
• Inhibition of α2,6-sialyltransferase relieves symptoms of ulcerative colitis by regulating Th17 cells polarization.

  2023cites this paper
• The pentraxin family in autoimmune disease.

  2023cites this paper
• Clinical significance of the C-reactive protein-to-bilirubin ratio in patients with ulcerative colitis

  2023cites this paper
• Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis

  2023cites this paper
• Development of a scoring system for predicting the severity of ulcerative colitis.

  2023cites this paper
• Evaluation of fecal Activin-A as a novel biomarker for early diagnosis of ulcerative colitis using experimental murine animal model.

  2023cites this paper
• Hyper α2,6‐Sialylation Promotes CD4+ T‐Cell Activation and Induces the Occurrence of Ulcerative Colitis

  2023cites this paper
• The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Serum level of S100A8/A9 as a biomarker for establishing the diagnosis and severity of community-acquired pneumonia in children

  2023cites this paper
• Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease

  2023cites this paper
• The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.

  2023cites this paper
• Identifying radiomic features associated with disease activity, patient outcomes, and serum phenotypes in pediatric Crohn's disease via MRI

  2022cites this paper
• Clinical Impact of Endoscopic Evaluation of the Small Bowel in Crohn’s Disease

  2022cites this paper
• Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.

  2022cites this paper
• Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study.

  2022cites this paper
• Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity.

  2022cites this paper
• Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease

  2022cites this paper
• Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease

  2022cites this paper
• Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes

  2022cites this paper
• A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis

  2022cites this paper
• A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation

  2022cites this paper
• Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease

  2022cites this paper
• Bowel ultrasound enhances predictive value based on clinical indicators: a scoring system for moderate-to-severe endoscopic activities in patients with ulcerative colitis

  2021cites this paper
• Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study

  2021cites this paper
• Clinical Practice Survey of Repeat Endoscopy in Pediatric Inflammatory Bowel Disease in North America

  2021cites this paper
• The “Gum–Gut” Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances

  2021cites this paper
• Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease

  2021cites this paper
• Integrating Expert ODEs into Neural ODEs: Pharmacology and Disease Progression

  2021cites this paper
• Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis

  2021cites this paper
• Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab

  2021cites this paper
• Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions

  2021cites this paper
• Guía de endoscopia en enfermedad inflamatoria intestinal

  2021cites this paper
• Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?

  2021cites this paper
• What Is a Flare? The Manitoba Living With IBD Study.

  2021cites this paper
• Biomarkers in chronic inflammatory bowel disease - present and future

  2020cites this paper
• CLEP_A_265404 1059..1072

  2020cites this paper
• Color Doppler Ultrasound Assessment of Clinical Activity in Inflammatory Bowel Disease.

  2020cites this paper
• JINLING (Judicious INdex of Luminal INflammation Grade) score, an effective indicator to assess inflammation severity in Crohn’s disease

  2020cites this paper
• Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases.

  2020cites this paper
• Moderate to Severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis.

  2020cites this paper
• Significance of Conducting 2 Types of Fecal Tests in Patients with Ulcerative Colitis.

  2020cites this paper
• Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.

  2020cites this paper
• An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score

  2020cites this paper
• Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study

  2020cites this paper
• Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease.

  2020cites this paper
• Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults

  2020cites this paper
• Assessment of the usefulness of imaging studies and biomarkers in the activity of Crohn’s disease

  2020cites this paper
• Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

  2020cites this paper
• Inter-Observer Agreement of a New Endoscopic Score for Ulcerative Colitis Activity: Preliminary Experience

  2020cites this paper
• Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors – A cross-sectional study

  2020cites this paper
• A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data

  2020cites this paper
• A Unified Treatment Algorithm and Admission Order Set for Pediatric Acute Pancreatitis.

  2019cites this paper
• Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn’s disease

  2019cites this paper
• Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review.

  2019cites this paper
• Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares.

  2019cites this paper
• Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease

  2019cites this paper
• Prediction of treatment outcome and relapse in inflammatory bowel disease

  2019influential citation
• DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in Ulcerative Colitis.

  2019cites this paper
• Letter to the Editor Re: Serum Calprotectin in Adolescents With Inflammatory Bowel Disease.

  2019cites this paper
• The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application.

  2019cites this paper
• Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn’s disease under treatment

  2019cites this paper
• A Novel Index to Measure Patient-Reported Outcomes in Clinical Practice and Research: The Inflammatory Bowel Disease Symptom Inventory-Ready for Prime Time?

  2019cites this paper
• More pictures: better clarity or more artifact.

  2019cites this paper
• The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study

  2019cites this paper
• Elevated Levels of Alveolar Nitric Oxide May Indicate Presence of Small Airway Inflammation in Patients with Inflammatory Bowel Disease

  2019cites this paper
• The PROMise of remote monitoring to improve quality of care for inflammatory bowel disease

  2019cites this paper
• Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients

  2019cites this paper
• Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis

  2019cites this paper
• The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease.

  2019cites this paper
• Comparison of small-bowel colon capsule endoscopy system to conventional colonoscopy for the evaluation of ulcerative colitis activity

  2019cites this paper
• Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland

  2019cites this paper
• Factors associated with disability in patients with ulcerative colitis: A cross‐sectional study

  2019cites this paper
• Systematic review and external validation of prediction models based on symptoms and biomarkers for identifying endoscopic activity in Crohn's disease.

  2019cites this paper
• Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.

  2018cites this paper
• Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.

  2018cites this paper
• Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon‐assisted endoscopy

  2018cites this paper
• disease with exclusive and partial enteral nutrition: a pilot

  2018cites this paper